Prognostic Value of C-Reactive Protein, Procalcitonin, and Interferon-Alpha in COVID-19 and Their Association with PANoptosis: A Cohort Study in Guangxi, China
Open Access
- 1 November 2025
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 15527-15542
Abstract
Objective: Numerous biomarkers of COVID-19 severity have been studied recently, while their relevance in the post-COVID-19 era requires further validation. This study sought to identify reliable biomarkers within a single cohort through a comprehensive comparative analysis and to investigate the underlying molecular mechanisms. Material and Methods: In this prospective, observational cohort study, we comprehensively assessed 41 markers in 97 COVID-19 pneumonia patients and 53 healthy volunteers. Receiver operating characteristics and Kaplan–Meier curves were plotted to determine the predictive value of effective biomarkers. Subsequently, flow cytometry, immunofluorescence, and Western blot analysis were conducted to evaluate the inflammatory cell death induced by the identified biomarkers in peripheral blood cells. Results: Based on the screening, plasma IL-6, IL-8, IL-10, IFN-α, PCT, and CRP at hospital admission were highly associated with disease severity (P < 0.001). A pairwise combination of CRP, PCT, and IFN-α could induce PANoptosis in neutrophils, lymphocytes, and platelets. Conclusion: The value of IL-6, IL-8, IL-10, IFN-α, PCT, and CRP in predicting the severity of COVID-19 was further verified in our study, and superior to novel biomarkers. Our data confirmed for the first time that CRP, PCT, and/or IFN-α triggers PANoptosis in lymphocytes, neutrophils, and platelets, which may prompt severe progression in COVID-19 patients.Keywords
This publication has 62 references indexed in Scilit:
- The emerging role of PANoptosis in viral infections diseaseCellular Signalling, 2024
- Diagnosis and treatment protocol for COVID‐19 patients (Tentative 10th Version)Health Care Science, 2023
- Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?Current Opinion in Virology, 2021
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock SyndromesCell, 2021
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19Cell, 2020
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Cell, 2020
- Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) InfectionArchives of Medical Research, 2020
- Type I Interferons in the Pathogenesis and Treatment of Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2020
- On the Alert for Cytokine Storm: Immunopathology in COVID‐19Arthritis & Rheumatology, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020